The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine

Existing vaccines may offer some protection against the rare strain now circulating—but the evidence is scant

Nearly 250 people are suspected to have died, and more than 1,100 are infected with the rare strain of Ebola in the DRC and Uganda, though the true spread of the virus is feared…